News

A large international study shows there is no increased risk of melanoma in rheumatoid arthritis disproving previous analyses.

Research from UNC may bring medicine closer to understanding the conundrum.

Pso and PsA are associated with higher rates of pathological fractures.

LFA-REAL offers a straight-forward evaluation for lupus-affected organ systems, a study shows.

In this case study, Dr. Litvin presents a complicated case of neuromyelitis optica (Devic’s disease), a rare inflammatory autoimmune CNS disease affecting the spinal cord and optic nerves.

A patient with uncontrolled hypertension, long-term Raynaud’s phenomenon, altered mental status, facial droop, dysarthria, diplopia and renal crisis.

Designated a breakthrough therapy for pemphigus vulgaris, rituximab has been shown to work better than prednisone alone and with fewer adverse events, researchers report in The Lancet.

Inflammatory bowel disease is associated with arthritis. Research suggests there could be a genetic component or the connection could be associated with an inflamed gut. Learn more here.

NIAID Director Anthony Fauci, MD is globally renowned for immunology research.

The first-ever treatment guidelines for systemic Sjogren’s syndrome have been issued highlighting the need to alleviate symptoms, improve quality of life and prevent further damage.

Patients sometimes insist on non-traditional therapies after a rheumatoid arthritis diagnosis. Their concerns shouldn't be ignored and instead, patients should be counseled on therapeutic options.

Patients with moderate to high total cholesterol and low-density lipoprotein levels are at increased risk for failed arthroscopic rotator cuff repair surgery, researchers reported at AAOS 2017 this week.

Researchers from the Netherlands compare three treatment options for patients with recent onset, non-systemic juvenile idiopathic arthritis.

Two new studies find that abatacept plus prednisone improves duration of remission for giant cell arteritis patients, but not for Takayasu’s arteritis patients.

The burden of arthritis is increasing on the nation as a whole and on individual patients, the CDC states in a new report.

A study spanning 18 years confirms that arthritis is up, people are being diagnosed at a younger age and with a higher BMI.

Rheumatoid arthritis patients treated with mavrilimumab had significantly reduced disease activity and greater ARC20 response compared to placebo in phase IIB study.

Two doses of sirukumab, compared with placebo, improves the signs and symptoms of patients with active rheumatoid arthritis, researchers report.

MRI measures appear to be on target with patient-reported outcomes in rheumatoid arthritis, researchers report in ARD.

Schizophrenia and rheumatoid arthritis appear to have a DNA level connection.

A new study finds that vitamin D supplementation is associated with lower rates of acute respiratory tract infections, especially in people who are vitamin D deficient.

For systemic lupus erythematosus patients prescribed glucocorticosteroids, mortality has been found to be more frequent than in patients not prescribed glucocorticosteroids, researchers say.

Despite good responses, patients dropped adalimumab treatment.

Patients who didn't respond to methotrexate may do well on baricitinib.

Researchers evaluated children with arthritis, uveitis, and both.

Facing a growing shortage, rheumatology is looking to attract the next generation of providers.

The U.S. Food and Drug Administration has approved brodalumab (Siliq) for the treatment of adults and moderate-to-severe plaque psoriasis.

Patient-reported outcomes are in line with clinical trial results for baricitinib, an international research team reports.

The 23-valent pneumococcal polysaccharide vaccine (PPSV23) does not prevent pneumonia in rheumatoid arthritis patients, a new study finds.

Brain changes that occur as a result of small vessel disease negatively effect gait in senior patients, research shows.